Territories of access

Information on the countries and territories that Our Future Health can and cannot grant access to data

Accessing Our Future Health data in different countries and territories

Our Future Health data is only available to access in specific countries and territories.

The table below lists the countries and territories Our Future Health can and cannot grant access to. Countries and territories are categorised as:

  • Accepted: Researchers or organisations based in these countries and territories can request access to the data Our Future Health holds via the Access Process. 

  • Under review: Our Future Health is currently reviewing this country or territory. 
  • Requires review/not listed: A review has not yet been undertaken. Any countries not listed in the table require further review by Our Future Health to determine whether access can or cannot be granted. If the study requests access to NHSE data, this review may include the requirement to submit an amendment to NHS England. This amendment would require approval before access could be granted. 
  • Not accepted: We are unable to issue access to the data Our Future Health holds. Countries/territories listed on the UK, EU and/or USA sanction lists and/or considered too high risk after review by the Our Future Health, cannot be granted access.  
Information:
Countries requiring International Data Transfer Agreements (IDTA)

Canada

Partial adequacy - only covers data that is subject to Canada's Personal Information Protection and Electronic Documents Act (PIPEDA). Not all data is subject to PIPEDA. ICO guidance states that an adequacy decision in place if data is processed in the course of ‘commercial activity’. Institutions should consider whether they consider themselves subject to the Canadian Personal Information Protection and Electronic Documents Act (PIPEDA) regarding their access to TRE data. Please read the guidance on the scope of PIPEDA from the Office of the Privacy Commissioner of Canada for further information.

Japan

Partial adequacy - only covers personal data transferred to private sector organisations subject to Japan’s Act on the Protection of Personal Information. This does not include transfers of the types listed in the EU’s adequacy decision for Japan.

United States of America

Partial adequacy - only covers data which is transferred under the UK Extension to the EU-US Data Privacy Framework. You can find more information about the UK Extension, including a factsheet for UK organisations, on gov.uk and on the US Department of Commerce’s Data Privacy Framework Program website.

Countries and territories of access

Country

Accepted to access Our Future Health data?

Accepted to access NHS England data?

Adequacy decision

Afghanistan

Not accepted

Andorra

Accepted

Accepted

European Commission’s adequacy decision

Australia

Partially accepted:
Research organisation must be bound by the Privacy Act and the Australia Privacy Principles.

Under review

None – IDTA required

Austria

Accepted

Accepted

EEA (EU)

Argentina

Accepted

Accepted

European Commission’s adequacy decision

Belarus

Not accepted

Belgium

Accepted

Accepted

EEA (EU)

Bosnia and Herzegovina

Not accepted

Bulgaria

Accepted

Accepted

EEA (EU)

Burundi

Not accepted

Canada

Accepted

Accepted

IDTA may be required

Central African Republic

Not accepted

Congo, Democratic Republic of

Not accepted

Crimea, Autonomous Republic of (Crimea Region of Ukraine)

Not accepted

Croatia

Accepted

Accepted

EEA (EU)

Cuba

Not accepted

Cyprus

Accepted

Accepted

EEA (EU)

Czech Republic

Accepted

Accepted

EEA (EU)

Denmark

Accepted

Accepted

EEA (EU)

Estonia

Accepted

Accepted

EEA (EU)

EU or EEA institutions, bodies, offices, or agencies

Accepted

Accepted

EEA

Faroe Islands

Accepted

Accepted

European Commission’s adequacy decision

Finland

Accepted

Accepted

EEA (EU)

France

Accepted

Accepted

EEA (EU)

Germany

Accepted

Accepted

EEA (EU)

Gibraltar

Accepted

Accepted

UK adequacy decision

Greece

Accepted

Accepted

EEA

Guernsey

Accepted

Accepted

European Commission’s adequacy decision

Guinea, Republic of

Not accepted

Guinea-Bissau, Republic of

Not accepted

Haiti

Not accepted

Hungary

Accepted

Accepted

EEA (EU)

Iceland

Accepted

Accepted

EEA (EFTA)

Iran

Not accepted

Iraq

Not accepted

Ireland

Accepted

Accepted

EEA (EU)

Isle of Man

Accepted

Accepted

European Commission’s adequacy decision

Israel

Accepted

Accepted

European Commission’s adequacy decision

Italy

Accepted

Accepted

EEA (EU)

Japan

Accepted

Accepted

IDTA may be required

Jersey

Accepted

Accepted

European Commission’s adequacy decision

Kenya

Accepted

Requires review

None – IDTA required

Korea, Democratic People’s Republic of (North Korea)

Not accepted

Korea, Republic of (South Korea)

Accepted

Accepted

UK adequacy decision

Latvia

Accepted

Accepted

EEA (EU)

Lebanon

Not accepted

Libya

Not accepted

Liechtenstein

Accepted

Accepted

EEA (EFTA)

Lithuania

Accepted

Accepted

EEA (EU)

Luxembourg

Accepted

Accepted

EEA (EU)

Mali

Not accepted

Malta

Accepted

Accepted

EEA (EU)

Moldova

Not accepted

Myanmar, Republic of the Union of

Not accepted

Netherlands

Accepted

Accepted

EEA (EU)

New Zealand

Accepted

Accepted

European Commission’s adequacy decision

Nicaragua

Not accepted

Norway

Accepted

Accepted

EEA (EFTA)

Poland

Accepted

Accepted

EEA (EU)

Portugal

Accepted

Accepted

EEA (EU)

Romania

Accepted

Accepted

EEA (EU)

Russia

Not accepted

Slovakia

Accepted

Accepted

EEA (EU)

Slovenia

Accepted

Accepted

EEA (EU)

Somalia

Not accepted

South Sudan

Not accepted

Spain

Accepted

Accepted

EEA (EU)

Sudan

Not accepted

Sweden

Accepted

Accepted

EEA (EU)

Switzerland

Accepted

Accepted

European Commission’s adequacy decision

Syria

Not accepted

Ukraine

Not accepted

Uruguay

Accepted

Accepted

European Commission’s adequacy decision

United States of America

Accepted

Accepted

IDTA may be required

Venezuela

Not accepted

Yemen

Not accepted

Zimbabwe

Not accepted

Updated: 03 February 2025